Michelle Mahler - 18 Mar 2026 Form 3 Insider Report for COMPUGEN LTD (CGEN)

Role
Chief Medical Officer
Signature
/s/ Michelle Mahler
Issuer symbol
CGEN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:11:49 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mahler Michelle Chief Medical Officer C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL /s/ Michelle Mahler 18 Mar 2026 0002041318

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGEN Ordinary Shares 23,125 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 40,000 $0.8793 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 35,750 $1.69 Direct F3
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 18,000 $1.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 20,122 restricted stock units ("RSUs"). 6,622 RSUs vest in 11 equal quarterly installments commencing on March 31, 2026; and 13,500 RSUs vest 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F2 This option vested 50% on December 31, 2025 and the remainder vested or vests in 8 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F3 This option vested 25% on September 30, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F4 This option vests 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.